April 24, 2025
The NIH campus in Bethesda, Md.
National Institutes of Health

STAT+ | NIH grants plummeted $2.3 billion in Trump’s first months, as federal-academia partnership crumbles

As Trump administration nears its 100th day, the partnership that has been propelling American biomedical innovation is imperiled

By Megan Molteni, J. Emory Parker, and Jonathan Wosen


Day by day, how Trump is roiling science and health

This timeline of the Trump administration documents decisions and events that have transpired with unprecedented speed since his inauguration

By Usha Lee McFarling


STAT+ | No new autism registry, HHS says walking back NIH director’s claim

The federal health department is not creating a new registry of Americans with autism, an HHS official said in a written statement Thursday.

By O. Rose Broderick



Robert F. Kennedy Jr. at the Rx and Illicit Drug Summit on Thursday in Nashville, Tenn.
George Walker IV/AP

RFK Jr. faces mixed reception, unruly crowd at major addiction conference   

Health Secretary Kennedy spoke at a large meeting of addiction experts, encountering both cheers and repeated protests.

By Lev Facher


STAT+ | New England Journal of Medicine gets swept up in U.S. attorney inquiry into alleged bias

The targeting of the prestigious publication — and perhaps others — could signal a coming clash between journals and the Trump administration.

By Anil Oza


Public health leaders, distrustful of RFK Jr., stand up project to defend vaccines 

The “Vaccine Integrity Project" will be aimed at assessing the best ways for vaccine proponents to safeguard vaccination policy and information.

By Helen Branswell


Molly Ferguson/STAT

STAT+ | Biotech is back, baby! It’s all upside from here

In this edition of "Adam's Biotech Scorecard," Adam is suddenly feeling quite cheery about everything. Or at least the market seems to feel that way.

By Adam Feuerstein


Opinion: The volunteer committee advising on newborn screening must be reinstated

Without the advisory committee, we have a gaping hole where a collective of leaders once championed for newborn health.

By Lillian Isabella


Pharma tariffs, and a ‘sunshine day’ for biotech stocks

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers Squibb drug.

By Elaine Chen, Adam Feuerstein, and Allison DeAngelis


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.